HKPD Cellyan Biotechnology Co., Ltd
USHealthcareAs of 2026-07-10 16:00
Why HKPD matters now
Cellyan Biotechnology Co., Ltd (HKPD) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.45 with -0.66% on the session and $4.9M in market capitalization; recent performance reads 1-month -26.03% and YTD -52.09%.
The latest financial table shown here is Q4 2025, with revenue of $9.2M, net income of $-855.6K, and EPS of $-0.08. Investors can compare that operating picture with valuation signals such as P/E 5.24 and FCF yield 9.6%.
Additional event context on this page matters because recent insider activity includes CHAN Kam Leung filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
5.24
PEG
—
P/B
0.71
P/S
0.21
EV/EBITDA
4.94
DCF Value
$0.81
FCF Yield
9.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.9%
Operating Margin
0.7%
Net Margin
-0.1%
ROE
-0.6%
ROA
-0.3%
ROIC
-1.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $9.2M | $-855.6K | $-0.08 |
| FY 2025 | $20.3M | $-27.1K | $-0.00 |
| Q2 2025 | $11.1M | $828.6K | $0.08 |
| Q4 2024 | $9.7M | $1.1M | $0.11 |
Trading Activity
Insider Trades
Related Stocks
Company Info
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
HK
Exchange
—
Beta
2.34
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.